Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Biome Australia Ltd ( (AU:BIO) ) has provided an update.
Biome Australia Limited has reported a significant increase in international sales revenue for FY25, achieving $1.5 million, a 69% rise from the previous fiscal year. The company has secured strategic distribution partnerships in Ireland, New Zealand, and Canada, positioning itself for substantial growth in FY26 by leveraging these new channels to enhance its market reach and brand recognition in the global health and wellness sector.
The most recent analyst rating on (AU:BIO) stock is a Buy with a A$0.85 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Limited is a microbiome health company that focuses on developing and distributing health solutions. The company is actively expanding its international presence, with a focus on strategic partnerships and distribution in key markets such as Canada, New Zealand, Ireland, and the United Kingdom.
Average Trading Volume: 302,901
Technical Sentiment Signal: Strong Buy
For an in-depth examination of BIO stock, go to TipRanks’ Overview page.